Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Understanding Benzodiazepine Withdrawal in Provincial Correctional Centres: A Mixed Methods Study

FY 2024-25

Summary
Overdose is the leading cause of death for British Columbians aged 10-59 years. Among people who died from overdose in 2020, 25% had been previously incarcerated in provincial correctional centres. Since October 2018, designer benzodiazepines detected in the illicit drug supply have complicated responding to the toxic drug crisis and providing substance use treatment services. Often mixed with high-dose opioids such as fentanyl, illicit benzodiazepines such as etizolam are an increasing public health threat due to extended periods of sedation and withdrawal complications.In the past 5 years, there has been a large increase in rates of opioid and benzodiazepine withdrawal, often occurring simultaneously, among people who are incarcerated in British Colombia's (BC) provincial correctional centres. Benzodiazepine withdrawal-related seizures and other adverse outcomes have become frequent events in correctional centres, where an estimated 70% of persons experience substance withdrawal. This project aims to learn more about how people in BC prisons experience withdrawal from benzodiazepines so that we are able to find better ways to support them to reduce adverse events like seizures and deaths in this growing population.The purpose of my research is to identify opportunities to improve support for persons experiencing benzodiazepine withdrawal from the perspective of incarcerated people using a mixed methods approach.The results of this project will directly inform the delivery of care to persons who experience illicit benzodiazepine withdrawal in provincial correctional centres. My research will provide foundational knowledge on benzodiazepine withdrawal that has implications for substance use treatment in prison and community settings throughout Canada.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530028
Name
Hoolsema Sidney
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding Benzodiazepine Withdrawal in Provincial Correctional Centres: A Mixed Methods Study
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Benzodiazepine; Incarceration; Overdose; Population Health; Substance Use
Abstract
Overdose is the leading cause of death for British Columbians aged 10-59 years. Among people who died from overdose in 2020, 25% had been previously incarcerated in provincial correctional centres. Since October 2018, designer benzodiazepines detected in the illicit drug supply have complicated responding to the toxic drug crisis and providing substance use treatment services. Often mixed with high-dose opioids such as fentanyl, illicit benzodiazepines such as etizolam are an increasing public health threat due to extended periods of sedation and withdrawal complications.In the past 5 years, there has been a large increase in rates of opioid and benzodiazepine withdrawal, often occurring simultaneously, among people who are incarcerated in British Colombia's (BC) provincial correctional centres. Benzodiazepine withdrawal-related seizures and other adverse outcomes have become frequent events in correctional centres, where an estimated 70% of persons experience substance withdrawal. This project aims to learn more about how people in BC prisons experience withdrawal from benzodiazepines so that we are able to find better ways to support them to reduce adverse events like seizures and deaths in this growing population.The purpose of my research is to identify opportunities to improve support for persons experiencing benzodiazepine withdrawal from the perspective of incarcerated people using a mixed methods approach.The results of this project will directly inform the delivery of care to persons who experience illicit benzodiazepine withdrawal in provincial correctional centres. My research will provide foundational knowledge on benzodiazepine withdrawal that has implications for substance use treatment in prison and community settings throughout Canada.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hoolsema, Sidney
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~